Laser zaps away reading glasses for Post-Cataract patients?
NCT ID NCT07384182
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a low-energy femtosecond laser (the Perfector device) to treat presbyopia in 19 people who already had monofocal lens implants from cataract surgery. The goal was to improve near and intermediate vision without harming distance vision. Participants were measured on how well they could read letters at 40 cm and 66 cm, and at 4 meters. The study is complete, but because it was small and had no comparison group, the results are preliminary.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
femtosecond laser device (Perfector)
What this could lead to
If it works, this could offer a way to improve reading vision without glasses for people who already have standard lens implants after cataract surgery.
What could go wrong
This was a very small study (19 people) with no control group, so results may not apply widely. The procedure involves attaching a device to the eye with suction, which carries some risk of discomfort or minor injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRESBYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gemini Eye Clinic
Zlín, Czech Republic, 760 01, Czechia